Agenda - Day 2 – Thursday, 12 SEPTEMBER

Key Sessions

Ankita Deshpande

Drugs, Devices & Digital: Looking to the Future of Healthcare and Life Sciences

Alexion

Jon Kiburz

Navigating the Pharma Deal Landscape: Achieving Successful Negotiations and Seamless Transactions

GSK

Nina Kjellson

The Biotech Survival Guide: Advice for the Current Market and Forward Thinking

Canaan Partners

Helen Ho

Exploring Factors that Drive Biotech Deals: Areas of Focus and Future Strategies

Blueprint Medicines

Day 2 – Thursday, 12 SEPTEMBERThursday, September 12, 2024 - ET (Eastern Time, GMT-05:00)

8:00am - 9:00am

Registration & Breakfast

Showing 3 of 3 Streams

BIOTECH LEADERS MORNING KEYNOTE PLENARY : ROOM 312

MEDTECH LEADERS : ROOM 306

HEALTHTECH LEADERS : ROOM 309

9:00am - 9:05am

LSX Welcome Address

Adam Griffiths - Senior Director, Biotech Lead, Informa

9:05am - 10:00am

Navigating the Pharma Deal Landscape: Achieving Successful Negotiations and Seamless Transactions

Jon Kiburz - VP Transactions, R&D Business Development, GSK
Herman Sanchez - Chief Business Officer, Trinity Life Sciences
Michal Preminger - Head, Johnson & Johnson Innovation East North America, Johnson & Johnson
Ramlah Nehring - Global Head of Partnering, VP Strategy & Transactions, Roche
Kendra Rose - Senior Vice President and Head of BD&L, Bayer
Konstantina Katcheves - SVP, Head of Innovative Medicines Business Development and Acquisitions, Teva Pharmaceuticals

10:00am - 10:30am

Startup Success: Securing an $80M Series A to Scale Regeneration Tech

Nabiha Saklayen - CEO & Founder, Cellino Biotech
Anula Jayasuriya - Co-Founder, Kidron Capital

9:00am - 9:10am

LSX Welcome Address

9:10am - 9:50am

Bold Moves and Buyouts: The Medtech 2025 M&A Blueprint

Jim Parshall - Executive Director, Delivery Device R&D, Eli Lilly
Wayne Jarvis - Senior Director BD & Portfolio Strategy, Coloplast
Kevin Tahmoush - International Healthcare Executive, Former VP Business Development, BD
Denise Clarke - Director, Strategy & Business Development, Philips Healthcare
Ilana Gotlib - Senior Director, Strategy & BD, Stryker

9:50am - 10:30am

Medtech Payoff: The Foundations Of Successful Provider & Payer Relationships

Georgia Mitsi - Partner, Business and Competitive Strategy, Y Innovations
Christian Howell - CEO, Cognito Therapeutics
Carolina Aguilar - CEO, INBRAIN Neuroelectronics
Willem Baralt - International Medtech Executive, Independent
Chris Springate - CEO, ARC Medical

9:00am - 9:10am

Welcome Address

9:10am - 9:50am

Leveraging Tech – How Can We Employ Data to Effectively Deliver on A Patient Centric Mission?

Andrei Georgescu - CEO, Vivodyne
Amit Garg - CEO, HiLabs
Shruthi Bharadwaj - Global Lead, R&D Insights & Analytics, Sanofi
Russell DeLapp - Industry Solutions Principal, Life Sciences, NTT DATA
Jayne Bower - Industry Executive Advisor, SAP

9:50am - 10:30am

Scaling RWE Generation & Integration

Wendy Turenne - SVP, Real World Data & Operations, Aetion
Joris Van Dam - VP Data Innovation, Exact Sciences
Brian Clancy - RWD & RWE Partnerships Lead, Foundation Medicine
Sherry Xiao - Senior Director, Integrated Evidence Generation, Pfizer
Rebecca Miksad - Chief Medical Officer, Color Health

10:30am - 11:00am

MORNING BREAK

Showing 5 of 5 Streams

CAPITAL MARKETS & INVESTMENT : ROOM 312

PARTNERSHIPS & DEAL MAKING : ROOM 311

SCALING & COMMERCIALISATION : ROOM 310

MEDTECH LEADERS : ROOM 306

HEALTHTECH LEADERS : ROOM 309

11:00am - 11:50am

Will IPOs Be Invite Only? Navigating the Journey to the Public Markets

Maha Radhakrishnan - Executive Partner, Sofinnova Investments
Adit Ghosh - Venture Capital Associate, NEA
James Graham - CEO, Recce Pharmaceutical
Sourav Sinha, Life Science Growth Investor
Mark Springel - Senior Associate, Vida Ventures

11:50am - 12:40pm

Charting the Public Waters: The Biotech Public Market Outlook

Mary Schaheen - President, Prevail Partners
Steve DiPalma - Managing Director, Danforth Advisors
Troy Ignelzi - CFO, Rapport Therapeutics
Mahesh Narayanan - Managing Partner, Neuvation Ventures

12:40pm - 1:20pm

The Biotech Survival Guide: Advice for the Current Market and Forward Thinking

Nina Kjellson - General Partner, Canaan Partners
Laura Berner - COO, TRexBio
Bernard Cooney - Senior Partner, Flagship Pioneering
Seth Lieblich - Principal, 8VC
Devin Rosenthal - VP & Head of Due Diligence, NovaQuest Capital Management

11:00am - 11:50am

Exploring Factors that Drive Biotech Deals: Areas of Focus and Future Strategies

Helen Ho - CBO, Blueprint Medicines
Jose Navarro - Scientific Director, quadraScope Ventures
Ahmed Mousa - CEO, Vicore Pharma
Faical Miyara - CBO, IO Biotech
John Harlow - CCO, Melinta Therapeutics

11:50am - 12:40pm

Navigating Innovation: Strategic Insights into Licensing Approaches in Pharma and Biotech

Ryan O’Quinn - Partner, Finnegan
Armin Rump - Associate Director, Global Business Development, Otsuka
Neel Desai - Executive Director, Business Development & Licensing, Biogen
Christopher Tan - Executive Director, BD&L, Merck
David Blair - Director, Strategic Partnering (Immunology), Global BD&L, Boehringer Ingelheim

12:40pm - 1:20pm

Partnering Early with Pharma to Achieve Transformative Innovation

Millie Nelson - Editor, BioXconomy, Informa Connect Life Sciences
Alex Goddard - Director, McQuade Center for Strategic R&D, Otsuka
Lizabeth Leveille - VP BD&L, Head Boston & EU Innovation Hubs & Discovery Transactions, MSD
Tom Hopkins - Global Head of Lilly ExploR&D, Eli Lilly

11:00am - 11:50am

What is Required to Scale? Fast-Tracking Biotech Growth

Jenny Holt - Chief Development Officer, Ray Therapeutics
Vik Chawla - Managing Director, Portfolio Strategy & Transactions, Syneos Health
Samta Kundu - COO, Strand Therapeutics
Wyatt McDonnell - CEO, Infinimmune, Inc.
Ashley Zehnder, Ph.D. - CEO, Fauna Bio
Minji Kim - CBO, Mineralys Therapeutics

11:50am - 12:40pm

Cultivating Success: Establishing an Outstanding Biotech Executive Team

Leslie Loveless - CEO, Slone Partners
Semi Trotto - Chief People Officer, Curie.Bio
Elaine Cheung - CBO, Moonwalk Biosciences
Lihua Zheng - CEO & Founder, Z-Star Therapeutics
Mike Curtis - President & CEO, eGenesis

12:40pm - 1:20pm

Considerations and Opportunities for Biotech & Pharma Within the APAC Region

Derek Yuan - Managing Director, LYFE Capital
Visali Ramanathan - Head of BD, Oncology, Genentech
Donald Xu - Managing Partner, Lynx Capital
Stephanie Marrus - Managing Director, Entrepreneurship, UCSF

11:00am - 11:50am

MedTech's Sustainability Ultimatum: Innovate or Stagnate

Amit Limaye - Director, Sustainable Medical Technology Institute (SMTI), BD
Samantha Smith - Director of Product Stewardship, Medtronic
Jamie Pero Parker - Sustainability Lead, RTI International

11:50am - 12:40pm

Cash, Crew, and Commercialisation: A Startup's Journey to Success

Darwin Shurig - CEO & Co-Founder, Shurig Solutions, Inc.
Carla Reimold - VP of Industry Strategy & Investments, Massachusetts Life Sciences Center
Sergio Levi - Chief Strategy and Business Officer, Nitinotes Surgical
Romeo Catracchia - CEO, AutonomUS, Inc.
Esmeralda Megally - CEO & Co-founder, Xsensio

12:40pm - 1:20pm

The Rx for a Successful Exit

Sourav Sinha, Life Science Growth Investor
Nate Harrington - Managing Partner, Philips
Maria Shepherd - Executive Board Member, MedExec Women
Giles Hamilton - Operating Partner, New Growth Advisors
Kevin Reilly - Managing Director, Head of Medtech, Ally Bridge Group

11:00am - 11:50am

Making Healthcare Fairer & More Equitable Across the Nation

Michael Pace - CEO & Co-Founder, PalmHealthCo
Willie Reaves - Head of Public Engagement, Cellino
Keely Benson - Director, Massachusetts eHealth Institute, MassTech
Arianne Kidder - Partner, Seae Ventures
Dora Green - Director, US Health Equity, Takeda

11:50am - 12:40pm

The Convergence of Biopharma, Medtech & Healthtech – What Does This Mean for The Future of Healthcare Delivery?

Chris Leggett - Senior Director & Head of Market Transformation, Vertex Pharmaceuticals
Paul Geevarghese - Co-Founder & COO, 9amHealth
Jim Parshall - Executive Director, Delivery Device R&D, Eli Lilly
Jeff Chu - Managing Partner, Features Capital
Naomi Fried - CEO & Founder, PharmStars
Oliver Barnes - Correspondent, The Financial Times

12:40pm - 1:20pm

Unveiling CVC Investment Strategies in Digital Health & MedTech

Alex de Winter - VP New Ventures, Danaher Ventures
Suzie Yoon - Investment Principal, Takeda Digital Ventures
Carrie Williams - VP & Partner, McKesson Ventures
John Pavletic - Executive Director, Lilly Ventures
Vijay Kori - Head of Strategic Finance, Redesign Health
Joe Heanue - CEO, Triple Ring Technologies

1:20pm - 2:20pm

LUNCH BREAK

Showing 1 of 1 Streams

LSX WORLD CONGRESS USA AFTERNOON KEYNOTE PLENARY : ROOM 312

2:20pm - 3:10pm

What Does the 2024 Presidential Election Mean for Patients and Innovation?

John Pracyk - SVP, Chief Medical Safety Officer - Global, Olympus Corporation
Maria Shepherd - Executive Board Member, MedExec Women
Haile Dagne - Director, Policy & Reimbursement, GSK
Andy Molnar - CEO, Digital Therapeutics Alliance
Rachel Hutman - CEO, Ford Hutman Media

3:10pm - 4:00pm

Drugs, Devices & Digital: Looking to the Future of Healthcare and Life Sciences

Ankita Deshpande - Former, Head Digital Health & Experience Innovation, Alexion
Steve Hahn - CEO-Partner, Flagship Pioneering
Ravi Kaushik - VP, Global Head of Device & Digital Innovation & Prod Strategy, Plasma Derived Therapies, Takeda
Emilia Javorksy - Director, Futures Program, Future of Life Institute
Geof Hannigan - Executive Director, Merck Digital Sciences Studio

4:00pm - 4:05pm

CLOSE OF CONGRESS

Day 2 – Thursday, 12 SEPTEMBERThursday, September 12, 2024 - ET (Eastern Time, GMT-05:00)

Get the Latest Event Updates